ApiJect Systems announced today that Edward Kelley has joined as chief global health officer for the company.
Kelley will take on the role at Stamford, Connecticut-based ApiJect, which provides a platform for pharmaceutical companies to fill-finish their injectable medicines in prefilled delivery systems, as well as become a leader of its related organizations, ApiLabs and the ApiJect Global Initiative.
ApiJect said in a news release that Kelly will help to lead its effort to develop upstream product ideas for serving both global markets and individual patients while he establishes and manages relationships with governments and non-profit healthcare providers.
Kelley will also serve as chief global health officer at ApiLabs and as executive director of the ApiJect Global Initiative. He joins the company and its related organizations after spending 15 years with the World Health Organization (WHO), with his most recent role being director of integrated health services.
Before WHO, Kelley was director of the U.S. National Healthcare Reports for the U.S. Department of Health and Human Services (HHS) in the Agency for Healthcare Research and Quality for nearly a decade.
“Ed Kelley is among the world’s most accomplished leaders in public health,” ApiJect Chairperson Jay Walker said in the release. “We are fortunate he has decided to join ApiJect’s team, where he elevates our role in addressing critical needs in global heath. As a public benefit corporation founded to address injection safety and primary healthcare needs, ApiJect appreciates Ed’s history of strengthening primary health care and making health services safe around the world.
“This sterling record will ensure that ApiJect and ApiLabs fulfill their mission to make essential injectable medicines and vaccines a realistic possibility that is well within reach for all communities, especially the most difficult to serve.”
